Reuters logo
7 months ago
BRIEF-Genmab: studies of Daratumumab (DARZALEX) in combination with Nivolumab
January 5, 2017 / 12:49 PM / 7 months ago

BRIEF-Genmab: studies of Daratumumab (DARZALEX) in combination with Nivolumab

1 Min Read

Jan 5 (Reuters) - Genmab A/S :

* Announces studies of Daratumumab (Darzalex) in combination with Nivolumab in solid tumors and multiple myeloma

* Phase IB/II studies of Daratumumab to start in 2017

* Studies will be sponsored by Bristol-Myers Squibb Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below